Amplify Alternative Harvest ETF (MJ)
The Amplify Alternative Harvest ETF (ticker: MJ) is an actively managed exchange-traded fund that invests in companies involved in the cultivation, processing, distribution, and retail sale of cannabis and hemp products, as well as businesses that supply equipment and services to the cannabis industry.
A fund that bets on an emerging legal market, not on legalization itself.
Unlike most sector ETFs, which track an index passively, MJ relies on active management. A dedicated portfolio team makes the buying and selling decisions, which means the fund’s composition reflects judgment about which cannabis-sector businesses offer the best value at any given time. This structure gives the fund flexibility to pivot as the industry evolves — something particularly valuable in cannabis, where state and federal regulation shift regularly and the competitive landscape is still taking shape.
The fund’s holdings span the full cannabis supply chain. On one end sit the large-scale cultivators and producers — licensed farms that grow cannabis and hemp in bulk. On the other sit retailers, from small independent shops to larger chains operating across multiple states. In the middle are processors, wholesalers, and the equipment and infrastructure companies that service growers — lighting systems, nutrients, real-estate landlords who lease to cannabis businesses, and logistics providers. The fund will also own ancillary businesses: testing labs, marketing firms, law practices specialising in cannabis regulation, and businesses selling products that compete with cannabis (such as hemp-derived CBD products) but exist in the same regulatory ecosystem.
Why the cannabis industry matters as an investment theme
Cannabis remains federally illegal in the United States, which creates both the opportunity and the risk. Legal at the state level in many jurisdictions, cannabis has grown from underground markets into a regulated, taxed industry with meaningful economic scale. Growers and retailers file taxes, report earnings, and operate above board — yet they cannot cross state lines, cannot easily access banking services, and face federal tax treatment (Internal Revenue Code Section 280E) that disallows standard business deductions. This asymmetry means the industry operates with unusual constraints, but within those constraints it is real and measurable.
The addressable market includes not only recreational cannabis but medical cannabis, hemp-derived products (including CBD), and the ancillary services that supply the industry. Over time, as more states legalised or liberalised cannabis, the revenue base of licensed operators expanded.
The fund’s strategy and risks
MJ’s active management means it charges higher fees than a passive cannabis index ETF would, but the intent is to generate alpha — returns above what a simple index approach would deliver. The fund’s managers are tasked with picking the cannabis companies most likely to prosper, whether because of operational excellence, market position, or valuation discipline.
The volatility of cannabis stocks is pronounced. Regulatory uncertainty — whether a given state will allow more licenses, how heavily it will tax operators, whether the federal government will shift its stance — drives large price swings. Individual companies face operational risks: licensing challenges, crop failures, execution missteps, and the difficulty of raising capital (owing to federal restrictions on banking and securities offerings). Concentration is another risk: the fund’s top holdings may represent a meaningful fraction of the portfolio, so the success or failure of a few large cultivators moves the fund’s value significantly.
For investors who believe the industry will mature over time and that some operators will emerge as durable, profitable businesses, the fund offers a simplified way to gain exposure to the space without picking individual stocks. But it is not a liquid, low-volatility holding — it is a conviction bet on the industry’s long-term viability within the U.S. legal framework.
How to research and track MJ
Start with the fund’s prospectus and holdings list, updated quarterly, which shows exactly which cannabis businesses the fund owns and in what proportion. Watch quarterly earnings reports from the fund’s largest holdings — cultivators like Tilray or Canopy Growth, retailers, and major ancillary-service providers — to gauge whether the industry is operationally improving or struggling. Federal regulatory developments matter enormously: if the U.S. Congress were to reschedule cannabis or allow interstate commerce, the investment thesis would shift significantly. Monitor the state-level regulatory environment, especially in large markets like California and Colorado, where price pressures and licensing policies directly affect growers’ profitability. ETFdb and Morningstar publish the fund’s historical performance, expense ratio, and sample holdings; the fund’s own website carries the latest prospectus and fact sheet.